You are viewing an incomplete version of our website. Please click to reload the website as full version.

Charged Multivesicular Body Protein 2A (CHMP2A) (N-Term) antibody

Details for Product No. ABIN350223, Supplier: Login to see New
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Synonyms BC-2, BC2, CHMP2, VPS2, VPS2A, 1500016L11Rik, RGD1305050, bc-2, bc2, chmp2, vps2, vps2a, fj10d05, wu:fi18h03, wu:fj10d05, zgc:55361
(13), (2), (2), (2), (1), (1)
Mouse (Murine), Rat (Rattus), Human
(46), (17), (17)
(43), (3)
(6), (6), (6), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Immunohistochemistry (IHC), Western Blotting (WB)
(25), (20), (11), (8), (4)
Pubmed 5 references available
Supplier Login to see New
Catalog number from supplier Login to see New
Quantity 100 μL
Shipping to United States ( )
Availability Will be delivered in 7 to 8 Business Days
Immunogen A synthetic peptide from the n-terminal of human CHMP2A conjugated to an immunogenic carrier protein was used as the antigen. The peptide is homologous in rat and mouse.
Specificity Specific for CHMP2A.
Purification Whole serum
Alternative Name CHMP2A (CHMP2A Antibody Abstract)
Background Function: Component of the ESCRT-III complex, which is required for multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. The MVB pathway mediates delivery oftransmembrane proteins into the lumen of the lysosome for degradation. The ESCRT-III complex is probably involved in the concentration of MVB cargo. In case of infection, the HIV-1 virus takes advantage of the ESCRT-III complex for budding and exocytic cargos of viral proteins.
Subcellular location: Late endosome membrane, Peripheral membrane protein, Cytoplasmic side.
Miscellaneous: Its overexpression strongly inhibits HIV-1 release. Also known as: Chromatin-modifying protein 2a, Vacuolar protein-sorting-associated protein 2-1, Vps2-1, hVps2-1, Putative breast adenocarcinoma marker BC-2, BC2, Charged multivesicular body protein 2a.
Research Area Signaling
Application Notes A dilution of 1 : 300 to 1 : 2000 is recommended.
The optimal dilution should be determined by the end user. Not tested in other applications.
Restrictions For Research Use only
Format Lyophilized
Reconstitution Reconstitute in 100 µL of sterile water. Centrifuge to remove any insoluble material.
Handling Advice Avoid freeze and thaw cycles.
Storage 4 °C/-20 °C
Storage Comment Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.
Expiry Date 12 months
Background publications Nousiainen, Silljé, Sauer et al.: "Phosphoproteome analysis of the human mitotic spindle." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, Issue 14, pp. 5391-6, 2006 (PubMed).

Kemmer, Podowski, Arenillas et al.: "NovelFam3000--uncharacterized human protein domains conserved across model organisms." in: BMC genomics, Vol. 7, pp. 48, 2006 (PubMed).

von Schwedler, Stuchell, Müller et al.: "The protein network of HIV budding." in: Cell, Vol. 114, Issue 6, pp. 701-13, 2003 (PubMed).

Gevaert, Goethals, Martens et al.: "Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides." in: Nature biotechnology, Vol. 21, Issue 5, pp. 566-9, 2003 (PubMed).

Howard, Stauffer, Degnin et al.: "CHMP1 functions as a member of a newly defined family of vesicle trafficking proteins." in: Journal of cell science, Vol. 114, Issue Pt 13, pp. 2395-404, 2001 (PubMed).

Catalog No. ABIN350223
Plus shipping costs $45.00

Order hotline:

  • +1 877 302 8632
  • +1 888 205 9894 (TF)